Charles River Associates publishes CRA Insights, a newsletter highlighting recent thinking and announcements from members of our Life Sciences Practice.
Rare disease PMA trends in France: Price achieved vs. disease prevalence
In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.